Navigation Links
Fertility Nutraceuticals, LLC Announces Release of OVOENERGEN™ CoQ10 Fertility Supplement for Women

New York City, NY (PRWEB) August 19, 2013

Fertility Nutraceuticals, LLC, a leading supplier of men’s and women’s fertility supplement products, announced the release of their newest fertility product for women, OVOENERGEN™. OVOENERGEN™ is a mega-dose nutritional supplement of pharmaceutical-grade coenzyme Q10 (CoQ10), developed in consultation with Dr. Robert Casper, Senior Investigator at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, Canada, the leading fertility expert and researcher of CoQ10 in women. OVOENERGEN™ CoQ10 is specifically designed to enhance female fertility by improving overall egg quality.

The CoQ10 in OVOENERGEN™ is a vitamin-like substance that acts as an antioxidant found throughout the body. CoQ10 has been used for a long time in male fertility context, but its use in women trying to conceive has drawn attention only recently. Dr. Casper’s preliminary study using 1000 mg daily of CoQ10 supplementation has shown its promising ability to support healthy egg development in the ovary. OVOENERGEN™ CoQ10 has been developed to replicate this experience.

Every package of OVOENERGEN™ contains four sheets of 21 soft gels, to be taken three times a day, seven days a week (84 soft gels total). OVOENERGEN™ is competitively priced at $195 per month and delivers more than three times the amount of CoQ10 per serving as in most other CoQ10 supplements. OVOENERGEN™ is available now and can be purchased via the Fertility Nutraceuticals, LLC’s

In addition to OVOENERGEN™, Fertility Nutraceuticals, LLC has also released ANDROENERGEN™ for men. ANDROENERGEN™ is a fertility supplement designed to support healthy sperm development.

About Fertility Nutraceuticals, LLC:

Fertility Nutraceuticals, LLC is a young company exclusively dedicated to highest-quality nutritional supplements for fertility. FERTINATAL® DHEA supplement is the company’s flagship product, with OVOENERGEN™ and ANDROENERGEN™ offering additional options. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Fertility therapy not associated with long-term cardiovascular disease
2. Women working shifts are at greater risk of miscarriage, menstrual disruption and subfertility
3. Fertility Specialist Calls Atlantic Article Disputing Age-Related Fertility Decline “Irresponsible”
4. Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies
5. Fertility Solutions Welcomes a New Doctor, Dr. Vasiliki Moragianni
6. Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld
7. Public Funding Spurs Couples to Seek Fertility Treatment
8. Testosterone Supplements May Hurt Male Fertility, Study Finds
9. Can High-Protein, Low-Carb Diet Boost Fertility Treatment?
10. Economics influence fertility rates more than other factors
11. Orange County Fertility Specialist Dr. Jane L. Frederick Donates $50,000 for Surrogate Bonding Room
Post Your Comments:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
Breaking Medicine Technology: